secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2023-08-03T23:59:59+00:00
Accession:  0000950170-23-037559
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Q2 net revenue $500.6M (+3% YoY); GAAP EPS $0.34, adjusted $0.39; EBITDA $59M
--------------------------------------------------------------------------------

- GAAP EPS from continuing ops $0.34 vs $0.36; adjusted EPS $0.39 vs $0.47 in prior year.
- Adjusted EBITDA $59.1M vs $65.6M YoY; 2023 EBITDA guidance reaffirmed at $235-245M.
- Same-unit revenue up 3.2% (reimbursement +2.6%, volume +0.6%); no CARES Act funds in Q2.
- Cash from ops $92.6M (+$11M YoY); capex $8.1M; total debt $675M.
- Weighted average shares fell to 82.7M from 85.6M due to share repurchases.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017023037559/0000950170-23-037559-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017023037559/md-20230803.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-037559

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer